80 research outputs found
Oceanic drivers of sei whale distribution in the North Atlantic
NRM was supported by Colciencias (Departamento Administrativo de Ciencia, TecnologĂa e InnovaciĂłn, Colombia), the University of St Andrews, and NAMMCO.This study investigated the oceanic drivers of sei whale (Balaenoptera borealis) distribution in the central and eastern North Atlantic, and explored how distribution may have changed over almost three decades. Cetacean sightings data were available from Icelandic, Faroese and Norwegian surveys conducted throughout the central and eastern North Atlantic during summer between 1987 and 2015. Effective strip half width was estimated from the data to take account of variation in detection probability. Spatially-referenced environmental variables used as predictors in generalised additive models of sei whale relative density included: relief-related variables seabed depth, slope and aspect; monthly-varying physical oceanographic variables sea surface temperature (SST), mixed layer depth, bottom temperature, salinity, and sea surface height anomaly (SSH); and monthly-varying biological oceanographic variables chlorophyll-a concentration and primary productivity. Preliminary analysis considered which month (March-August) in the dynamic oceanographic variables explained most variability in sei whale density. Models including all variables (âfull modelsâ) could only be run for 1998-2015 because data for several variables were missing in earlier years. âSimple models" including only relief-related variables and SST were therefore run for 1987-89, and also for 1998-2015 for comparison. The best-fitting full model for 1998-2015 retained the covariates depth, May SST, May bottom temperature, July salinity, July SSH and July primary productivity. Of these, depth, May SST and July SSH were the strongest predictors of sei whale density. In the simple models for both 1987-89 and 1998-2015, depth (especially), May SST and seabed slope were the strongest predictors of sei whale density. The highest densities of sei whales were predicted in the Irminger Sea and over the Charles-Gibbs Fracture Zone; a pattern driven by large negative SSH, deep water (>1500m) and polar-temperate SST (5-12oC). There was some inter-annual variability in predicted distribution and there appears to be a northward expansion in distribution consistent with prey species responding to ocean warming. The models could be used to predict future distribution of sei whales based on future environmental conditions predicted by climate models.Publisher PDFPeer reviewe
Stratification of PD-1 blockade response in melanoma using pre- and post-treatment immunophenotyping of peripheral blood
Efficacy of checkpoint inhibitor therapies in cancer varies greatly, with some patients showing complete responses while others do not respond and experience progressive disease. We aimed to identify correlates of response and progression following PD-1-directed therapy by immunophenotyping peripheral blood samples from 20 patients with advanced malignant melanoma before and after treatment with the PD-1 blocking antibody pembrolizumab. Our data reveal that individuals responding to PD-1 blockade were characterised by increased CD8 T cell proliferation following treatment, while progression was associated with an increase in CTLA-4-expressing Treg. Remarkably, unsupervised clustering analysis of pre-treatment T cell subsets revealed differences in individuals that went on to respond to PD-1 blockade compared to individuals that did not. These differences mapped to expression of the proliferation marker Ki67 and the costimulatory receptor CD28 as well as the inhibitory molecules 2B4 and KLRG1. While these results require validation in larger patient cohorts, they suggest that flow cytometric analysis of a relatively small number of T cell markers in peripheral blood could potentially allow stratification of PD-1 blockade treatment response prior to therapy initiation
IL-21 shapes germinal center polarization via light zone B cell selection and cyclin D3 upregulation
Germinal center (GC) dysregulation has been widely reported in the context of autoimmunity. Here, we show that interleukin 21 (IL-21), the archetypal follicular helper T cell (Tfh) cytokine, shapes the scale and polarization of spontaneous chronic autoimmune as well as transient immunization-induced GC. We find that IL-21 receptor deficiency results in smaller GC that are profoundly skewed toward a light zone GC B cell phenotype and that IL-21 plays a key role in selection of light zone GC B cells for entry to the dark zone. Light zone skewing has been previously reported in mice lacking the cell cycle regulator cyclin D3. We demonstrate that IL-21 triggers cyclin D3 upregulation in GC B cells, thereby tuning dark zone inertial cell cycling. Lastly, we identify Foxo1 regulation as a link between IL-21 signaling and GC dark zone formation. These findings reveal new biological roles for IL-21 within GC and have implications for autoimmune settings where IL-21 is overproduced
Understanding the perspectives of recruiters is key to improving randomised controlled trial enrolment: a qualitative evidence synthesis.
BackgroundRecruiting patients to randomised controlled trials (RCTs) is often reported to be challenging, and the evidence base for effective interventions that could be used by staff (recruiters) undertaking recruitment is lacking. Although the experiences and perspectives of recruiters have been widely reported, an evidence synthesis is required in order to inform the development of future interventions. This paper aims to address this by systematically searching and synthesising the evidence on recruiters' perspectives and experiences of recruiting patients into RCTs. METHODS: A qualitative evidence synthesis (QES) following Thomas and Harden's approach to thematic synthesis was conducted. The Ovid MEDLINE, CINAHL, EMBASE, PsycInfo, Cochrane Central Register of Controlled Trials, ORRCA and Web of Science electronic databases were searched. Studies were sampled to ensure that the focus of the research was aligned with the phenomena of interest of the QES, their methodological relevance to the QES question, and to include variation across the clinical areas of the studies. The GRADE CERQual framework was used to assess confidence in the review findings.ResultsIn total, 9316 studies were identified for screening, which resulted in 128 eligible papers. The application of the QES sampling strategy resulted in 30 papers being included in the final analysis. Five overlapping themes were identified which highlighted the complex manner in which recruiters experience RCT recruitment: (1) recruiting to RCTs in a clinical environment, (2) enthusiasm for the RCT, (3) making judgements about whether to approach a patient, (4) communication challenges, (5) interplay between recruiter and professional roles.ConclusionsThis QES identified factors which contribute to the complexities that recruiters can face in day-to-day clinical settings, and the influence recruiters and non-recruiting healthcare professionals have on opportunities afforded to patients for RCT participation. It has reinforced the importance of considering the clinical setting in its entirety when planning future RCTs and indicated the need to better normalise and support research if it is to become part of day-to-day practice.Trial registrationPROSPERO CRD42020141297 (registered 11/02/2020)
IL-21 shapes germinal center polarization via light zone B cell selection and cyclin D3 upregulation
Therapeutic gene editing of T cells to correct CTLA-4 insufficiency
Heterozygous mutations in CTLA-4 result in an inborn error of immunity with an autoimmune and frequently severe clinical phenotype. Autologous T cell gene therapy may offer a cure without the immunological complications of allogeneic hematopoietic stem cell transplantation. Here, we designed a homology-directed repair (HDR) gene editing strategy that inserts the CTLA-4 cDNA into the first intron of the CTLA-4 genomic locus in primary human T cells. This resulted in regulated expression of CTLA-4 in CD4+ T cells, and functional studies demonstrated CD80 and CD86 transendocytosis. Gene editing of T cells isolated from three patients with CTLA-4 insufficiency also restored CTLA-4 protein expression and rescued transendocytosis of CD80 and CD86 in vitro. Last, gene-corrected T cells from CTLA-4-/- mice engrafted and prevented lymphoproliferation in an in vivo murine model of CTLA-4 insufficiency. These results demonstrate the feasibility of a therapeutic approach using T cell gene therapy for CTLA-4 insufficiency
Does home equipment contribute to socioeconomic gradients in Australian childrenâs physical activity, sedentary time and screen time?
Pravastatin for early-onset pre-eclampsia:a randomised, blinded, placebo-controlled trial
Objective: Women with pre-eclampsia have elevated circulating levels of soluble fms-like tyrosine kinase-1 (sFlt-1). Statins can reduce sFlt-1 from cultured cells and improve pregnancy outcome in animals with a pre-eclampsia-like syndrome. We investigated the effect of pravastatin on plasma sFlt-1 levels during pre-eclampsia. Design: Blinded (clinician and participant), proof of principle, placebo-controlled trial. Setting: Fifteen UK maternity units. Population: We used a minimisation algorithm to assign 62 women with early-onset pre-eclampsia (24 +0â31 +6 weeks of gestation) to receive pravastatin 40 mg daily (n = 30) or matched placebo (n = 32), from randomisation to childbirth. Primary outcome: Difference in mean plasma sFlt-1 levels over the first 3 days following randomisation. Results: The difference in the mean maternal plasma sFlt-1 levels over the first 3 days after randomisation between the pravastatin (n = 27) and placebo (n = 29) groups was 292 pg/ml (95% CI â1175 to 592; P = 0.5), and over days 1â14 was 48 pg/ml (95% CI â1009 to 913; P = 0.9). Women who received pravastatin had a similar length of pregnancy following randomisation compared with those who received placebo (hazard ratio 0.84; 95% CI 0.50â1.40; P = 0.6). The median time from randomisation to childbirth was 9 days [interquartile range (IQR) 5â14 days] for the pravastatin group and 7 days (IQR 4â11 days) for the placebo group. There were three perinatal deaths in the placebo-treated group and no deaths or serious adverse events attributable to pravastatin. Conclusions: We found no evidence that pravastatin lowered maternal plasma sFlt-1 levels once early-onset pre-eclampsia had developed. Pravastatin appears to have no adverse perinatal effects. Tweetable abstract: Pravastatin does not improve maternal plasma sFlt-1 or placental growth factor levels following a diagnosis of early preterm pre-eclampsia #clinicaltrial finds
Seven features of safety in maternity units: a framework based on multisite ethnography and stakeholder consultation
Background: Reducing avoidable harm in maternity services is a priority globally. As well as learning from mistakes, it is important to produce rigorous descriptions of âwhat good looks likeâ. Objective: We aimed to characterise features of safety in maternity units and to generate a plain language framework that could be used to guide learning and improvement. Methods: We conducted a multisite ethnography involving 401 hours of non-participant observations 33 semistructured interviews with staff across six maternity units, and a stakeholder consultation involving 65 semistructured telephone interviews and one focus group. Results: We identified seven features of safety in maternity units and summarised them into a framework, named For Us (For Unit Safety). The features include: (1) commitment to safety and improvement at all levels, with everyone involved; (2) technical competence, supported by formal training and informal learning; (3) teamwork, cooperation and positive working relationships; (4) constant reinforcing of safe, ethical and respectful behaviours; (5) multiple problem-sensing systems, used as basis of action; (6) systems and processes designed for safety, and regularly reviewed and optimised; (7) effective coordination and ability to mobilise quickly. These features appear to have a synergistic character, such that each feature is necessary but not sufficient on its own: the features operate in concert through multiple forms of feedback and amplification. Conclusions: This large qualitative study has enabled the generation of a new plain language frameworkâFor Usâthat identifies the behaviours and practices that appear to be features of safe care in hospital-based maternity units
Multi-criteria correlation of tephra deposits to source centres applied in the Auckland Volcanic Field, New Zealand
- âŠ